pI: 8.3225 |
Length (AA): 317 |
MW (Da): 33358 |
Paralog Number:
2
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 314 | 9ldt (A) | 12 | 331 | 23.00 | 0 | 1 | 1.31 | -1.08 |
8 | 315 | 1smk (A) | 44 | 354 | 55.00 | 0 | 1 | 1.79 | -2.11 |
9 | 317 | 3hhp (A) | 1 | 312 | 53.00 | 0 | 1 | 1.69716 | -1.17 |
10 | 314 | 4e0b (A) | 2 | 308 | 53.00 | 0 | 1 | 1.66605 | -1.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127145)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G15020 | malate dehydrogenase 2 |
Arabidopsis thaliana | AT3G47520 | malate dehydrogenase |
Arabidopsis thaliana | AT5G09660 | peroxisomal NAD-malate dehydrogenase 2 |
Arabidopsis thaliana | AT1G53240 | malate dehydrogenase 1 |
Arabidopsis thaliana | AT2G22780 | peroxisomal NAD-malate dehydrogenase |
Brugia malayi | Bm1_46465 | Probable malate dehydrogenase, mitochondrial precursor |
Candida albicans | CaO19.7481 | similar to all three S. cerevisiae malate dehydrogenases (YKL085W, YDL078C, YOL126C) |
Candida albicans | CaO19.12072 | similar to S. cerevisiae MDH1 (YKL085W) mitochondrial malate dehydrogenase |
Candida albicans | CaO19.4602 | similar to S. cerevisiae MDH1 (YKL085W) mitochondrial malate dehydrogenase |
Candida albicans | CaO19.12783 | similar to S. cerevisiae MDH3 (YDL078C) peroxisomal malate dehydrogenase |
Candida albicans | CaO19.5323 | similar to S. cerevisiae MDH3 (YDL078C) peroxisomal malate dehydrogenase |
Caenorhabditis elegans | CELE_F20H11.3 | Protein MDH-2 |
Drosophila melanogaster | Dmel_CG7998 | Malate dehydrogenase 2 |
Escherichia coli | b3236 | malate dehydrogenase, NAD(P)-binding |
Echinococcus granulosus | EgrG_001185100 | malate dehydrogenase |
Echinococcus granulosus | EgrG_001185000 | malate dehydrogenase |
Echinococcus multilocularis | EmuJ_001185100 | malate dehydrogenase |
Echinococcus multilocularis | EmuJ_001185000 | malate dehydrogenase |
Homo sapiens | ENSG00000146701 | malate dehydrogenase 2, NAD (mitochondrial) |
Leishmania braziliensis | LbrM.20.0010 | mitochondrial malate dehydrogenase |
Leishmania braziliensis | LbrM.19.1020 | glycosomal malate dehydrogenase |
Leishmania braziliensis | LbrM.20.0030 | malate dehydrogenase |
Leishmania donovani | LdBPK_340170.1 | mitochondrial malate dehydrogenase |
Leishmania donovani | LdBPK_340150.1 | malate dehydrogenase |
Leishmania donovani | LdBPK_190710.1 | glycosomal malate dehydrogenase |
Leishmania infantum | LinJ.34.0150 | malate dehydrogenase |
Leishmania infantum | LinJ.34.0170 | mitochondrial malate dehydrogenase |
Leishmania infantum | LinJ.19.0710 | glycosomal malate dehydrogenase |
Leishmania major | LmjF.34.0140 | malate dehydrogenase |
Leishmania major | LmjF.34.0160 | mitochondrial malate dehydrogenase |
Leishmania major | LmjF.19.0710 | glycosomal malate dehydrogenase |
Leishmania mexicana | LmxM.33.0160 | malate dehydrogenase, putative |
Leishmania mexicana | LmxM.19.0710 | glycosomal malate dehydrogenase |
Leishmania mexicana | LmxM.33.0140 | malate dehydrogenase |
Loa Loa (eye worm) | LOAG_02046 | malate dehydrogenase |
Mus musculus | ENSMUSG00000019179 | malate dehydrogenase 2, NAD (mitochondrial) |
Oryza sativa | 4326249 | Os01g0649100 |
Oryza sativa | 4339682 | Os05g0574400 |
Oryza sativa | 4345657 | Os08g0434300 |
Oryza sativa | 4334274 | Os03g0773800 |
Oryza sativa | 4352871 | Os12g0632700 |
Oryza sativa | 4327423 | Os01g0829800 |
Oryza sativa | 4343993 | Os07g0630800 |
Saccharomyces cerevisiae | YKL085W | malate dehydrogenase MDH1 |
Schistosoma japonicum | Sjp_0024400 | ko:K00026 malate dehydrogenase [EC1.1.1.37B], putative |
Schistosoma mansoni | Smp_047370 | malate dehydrogenase |
Schmidtea mediterranea | mk4.000346.13 | Probable malate dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.000255.00 | Probable malate dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.003219.02 | Probable malate dehydrogenase, mitochondrial |
Schmidtea mediterranea | mk4.003441.01 | |
Trypanosoma brucei gambiense | Tbg972.10.18820 | glycosomal malate dehydrogenase, putative |
Trypanosoma brucei gambiense | Tbg972.10.3190 | mitochondrial malate dehydrogenase, putative |
Trypanosoma brucei | Tb927.10.15410 | glycosomal malate dehydrogenase |
Trypanosoma brucei | Tb927.10.2560 | mitochondrial malate dehydrogenase |
Trypanosoma congolense | TcIL3000_10_2190 | mitochondrial malate dehydrogenase |
Trypanosoma congolense | TcIL3000_10_13190 | glycosomal malate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.506503.69 | glycosomal malate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.506195.110 | malate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.507883.109 | mitochondrial malate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.511293.69 | glycosomal malate dehydrogenase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.2560 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.2560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.2560 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.2560 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.15410 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.15410 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.15410 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.15410 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3236 | Escherichia coli | non-essential | goodall |
CELE_F20H11.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F20H11.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F20H11.3 | Caenorhabditis elegans | slow growth | wormbase |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | malate dehydrogenase 2, NAD (mitochondrial) | Compounds | References |
Sus scrofa | Malate dehydrogenase mitochondrial | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
LmjF.34.0140 | cloned gene | BRENDA | A gene with this EC number or name or sequence has been cloned from Leishmania major ( 1 ) |
30 literature references were collected for this gene.